Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1977 Mar;30(3):250–253. doi: 10.1136/jcp.30.3.250

Polymorphonuclear leucocyte function in Behçet's disease.

J D Sobel, S Haim, N Obedeanu, T Meshulam, D Merzbach
PMCID: PMC476367  PMID: 845272

Abstract

Polymorphonuclear leucocyte function was investigated in 19 patients with active Behçet's disease. Spontaneous free leucocyte migration was found to be significantly reduced, yet after stimulation the leucocyte's chemotactic activity was considerably increase (p less than 0-05) when compared to control leucocytes. Control leucocytes migrated more rapidly when incubated in serum taken from patients with Behçet's disease (p less than 0-005). The enhanced chemotactic activity in Bechçet's disease appears to be due to both serum and intrinsic leucocyte factors. Spontaneous nitroblue tetrazolium reduction was found to be normal, although after stimulation leucocyte nitroblue tetrazolium reduction was lower than in the control group (P less than 0-025), as was leucocyte oxygen utilisation. It is suggested that the hyperreactive cellular inflammatory response that characterises Behçet's disease may be due to increased chemotactic activity and minor alterations in functional metabolic activity of leucocytes.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chajek T., Fainaru M. Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 1975 May;54(3):179–196. doi: 10.1097/00005792-197505000-00001. [DOI] [PubMed] [Google Scholar]
  2. Frei P. C., Baisero M. H., Ochsner M. Chemotaxis of human polymorphonuclears in vitro. II. Technical study. J Immunol Methods. 1974 Oct;5(4):375–386. doi: 10.1016/0022-1759(74)90021-0. [DOI] [PubMed] [Google Scholar]
  3. Gallin J. I., Clark R. A., Kimball H. R. Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes. J Immunol. 1973 Jan;110(1):233–240. [PubMed] [Google Scholar]
  4. Hill H. R., Warwick W. J., Dettloff J., Quie P. G. Neutrophil granulocyte function in patients with pulmonary infection. J Pediatr. 1974 Jan;84(1):55–58. doi: 10.1016/s0022-3476(74)80553-6. [DOI] [PubMed] [Google Scholar]
  5. Kogure M., Shimada K., Hara H. [Complement titer in patient with Behçet's disease]. Nippon Ganka Gakkai Zasshi. 1971;75(5):1260–1268. [PubMed] [Google Scholar]
  6. Matsumura N., Mizushima Y. Leucocyte movement and colchicine treatment in Behcet's disease. Lancet. 1975 Oct 25;2(7939):813–813. doi: 10.1016/s0140-6736(75)80031-6. [DOI] [PubMed] [Google Scholar]
  7. Merzbach D., Obedeanu N. Standardisation of the nitroblue-tetrazolium test. J Med Microbiol. 1975 May;8(2):375–384. doi: 10.1099/00222615-8-2-375. [DOI] [PubMed] [Google Scholar]
  8. Nelson R. D., Quie P. G., Simmons R. L. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol. 1975 Dec;115(6):1650–1656. [PubMed] [Google Scholar]
  9. Okuda K., Tanokoro I., Sekido M. Letter: The NBT test in Behçet's syndrome. N Engl J Med. 1974 Apr 18;290(16):915–916. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES